QCG
LEGN icon

Quadrant Capital Group’s Legend Biotech LEGN Stock Holding History

Quadrant Capital Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,959
Closed -$35.4K – 1972
2026
Q1 		$35.4K Sell
1,959
-291
-13% -$5.55K ﹤0.01% 1811
2025
Q4 		$48.9K Sell
2,250
-23,291
-91% -$667K ﹤0.01% 1689
2025
Q3 		$833K Buy
25,541
+12,716
+99% +$469K 0.03% 599
2025
Q2 		$455K Buy
12,825
+8,787
+218% +$285K 0.02% 929
2025
Q1 		$137K Buy
4,038
+213
+6% +$7.64K 0.01% 1441
2024
Q4 		$124K Buy
3,825
+3,738
+4,297% +$155K 0.01% 936
2024
Q3 		$4.24K Buy
87
+16
+23% +$852 ﹤0.01% 2355
2024
Q2 		$3.15K Buy
71
+8
+13% +$369 ﹤0.01% 2402
2024
Q1 		$3.53K Sell
63
-8
-11% -$482 ﹤0.01% 2398
2023
Q4 		$4.27K Buy
71
+48
+209% +$3.04K ﹤0.01% 2321
2023
Q3 		$1.54K Hold
23
– – ﹤0.01% 2443
2023
Q2 		$1.59K Hold
23
– – ﹤0.01% 2456
2023
Q1 		$1.11K Buy
23
+10
+77% +$489 ﹤0.01% 2534
2022
Q4 		$649 Buy
13
+5
+63% +$242 ﹤0.01% 2591
2022
Q3 		$0 Buy
+8
New +$375 ﹤0.01% 2728
2022
Q1 		– Sell
-214
Closed -$10K – 2599
2021
Q4 		$10K Sell
214
-66
-24% -$3.35K ﹤0.01% 1628
2021
Q3 		$14K Hold
280
– – ﹤0.01% 1426
2021
Q2 		$11K Hold
280
– – ﹤0.01% 1510
2021
Q1 		$8K Buy
280
+80
+40% +$2.18K ﹤0.01% 1607
2020
Q4 		$6K Hold
200
– – ﹤0.01% 1637
2020
Q3 		$6K Buy
+200
New +$6.73K ﹤0.01% 1464

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Quadrant Capital Group's LEGN Position: Q2 2026 in Review

Quadrant Capital Group sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 1,959 shares — an estimated $35.4K sold.

Quadrant Capital Group first reported a position in LEGN in Q3 2020 and held it in 21 quarters. The position peaked at $833K in Q3 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Quadrant Capital Group reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 1,959 Legend Biotech shares in Q2 2026, an estimated $35.4K.
  • Quadrant Capital Group first reported a position in Legend Biotech in Q3 2020 and held it in 21 quarters.
  • Quadrant Capital Group's Legend Biotech position peaked at $833K in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.